Overview

Duloxetine Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain in China

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
To determine if duloxetine 60mg up to 120mg daily can work in treating pain from Diabetic Neuropathy.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Boehringer Ingelheim
Treatments:
Duloxetine Hydrochloride